Skip to main content
2025 AABB Annual Meeting Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Event Icons
Assessor Sessions
Assessor Sessions
Committee Meetings
Committee Meetings
Foundation Events
Foundation Events
Networking Events
Networking Events
Oral Abstracts
Oral Abstracts
CABP Eligible
CABP Eligible
Video Recording

Biotherapies, Cellular Therapies, and Immunotherapies

AM25-MN-18-L - Oral Abstract Session - Advances in Cord Blood Therapy

Monday, October 27, 2025
10:00 AM - 10:45 AM  PT
Room:SDCC 32
CE: 0 CME (AMA Physician Credit) / .45 CE (Non-Physician Credit)

CABP Eligible

    Program Chair(s)

  • Colleen Delaney, MD, MSc (she/her/hers)

    VP and Chief Medical Officer; Interim Director; PI, Delaney Lab; Clinical Professor and Attending Physician, Stem Cell Transplant Service; Affiliate Investigator
    Seattle Children’s Therapeutics (SCTx); Clinical Cell Processing Laboratory (CCPL); Seattle Children’s Research Institute (SCRI); University of WA, Dep’t of Pediatrics; Fred Hutch Cancer Center
    seattle, Washington

    Handouts
Disclosure(s):
Colleen Delaney, MD, MSc: Celaid: Consultant/Advisory Board (Ongoing)

Presentations:

  • 10:00 AM - 10:45 AM  PT
    Analysis of Impact to HLA Coverage and Usability of Cord Blood Units Banked Between 2017 and 2024

    Presenting Author: Christina Melief, PhD – National Cord Blood Network

  • 10:00 AM - 10:45 AM  PT
    Ex Vivo and In Vivo Potency of CD34+ Hematopoietic Stem and Progenitor Cells Isolated from Cord Blood Using a Novel Technology

    Presenting Author: Jonathan Messer, PhD (he/him/his) – 42Bio

  • 10:00 AM - 10:45 AM  PT
    Umbilical Cord Blood Transplantation (UCBT) a Very Good Curative Option for Pediatric Patients with Congenital Disorders Even in the Setting of Underrepresented Minorities

    Presenting Author: Caridad Martinez, MD – Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital